Dosimetric comparison of the BNCT treatment planning performances when using a nnU-NET to automatically segment Glioblastoma Multiforme
Cristina Pezzi, Francesco Morosato, Barbara Marcaccio, Silva Bortolussi, Ricardo Luis Ramos, Valerio Vercesi, Ian Postuma, Setareh Fatemi

TL;DR
This study evaluates the use of nnU-NET, a convolutional neural network, for automatic segmentation of Glioblastoma Multiforme to assist in BNCT treatment planning, comparing dosimetric outcomes with manual contours.
Contribution
It introduces a novel application of nnU-NET for automatic tumor segmentation in BNCT, including a dosimetric comparison with manual delineation in clinical cases.
Findings
Automatic segmentation achieved high Dice Coefficient scores.
Differences in dosimetry between manual and automatic contours were minimal.
The method shows potential to streamline BNCT treatment planning.
Abstract
This work presents a preliminary evaluation of the use of the convolutional neural network nnU-NET to automatically contour the volume of Glioblastoma Multiforme in medical images of patients. The goal is to assist the preparation of the Treatment Planning of patients who undergo Boron Neutron Capture Therapy (BNCT). BNCT is a binary form of radiotherapy based on the selective loading of a suitable 10-boron concentration into the tumour and on subsequent low-energy neutron irradiation. The selectivity of the therapeutic effect is based on the capacity of the boron drug to target preferentially cancer cells, thus triggering the neutron capture only in the tumour and depositing there a lethal dose. Even if the tailoring of the beam to the tumour volume is less crucial for BNCT than for other radiation therapies, a proper delimitation of the tumour volume is needed to assess a safe and…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
